Health Trials

Myelodysplastic-Myeloproliferative Diseases

3

Review clinical trials related to Myelodysplastic-Myeloproliferative Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clonal Hematopoiesis of Immunological Significance

Ambispective, national, multicenter observational cohort study aimed at characterizing the satellite dysimmune manifestations of clonal hematopoiesis, including Vexas (Vacuoles, E1 enzyme, X-linked, Autoinflammatory and Somatic) syndrome.

Participants needed: 5,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Mar 23, 2026Locations: 1Duration: 10 Years
Eligibility criteria

Age >=18 years old; [+2]

Persons benefiting from special protection: adults under guardianship and curato... [+2]

Read more
Status: Recruiting

Italian Network MDS Registry

Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.

Participants needed: 10,000
Trial details
Age: 18-106Biological sex: AllType: ObservationalSponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETSUpdated: Mar 4, 2025Locations: 20Duration: 10 Years
Eligibility criteria

New diagnosis of MDS

Patient who refuse the signature of informed consent

Read more
Status: Recruiting

Myeloproliferative Neoplasms (MPNs) Patient Registry

The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.

Participants needed: 5,000
Trial details
Biological sex: AllType: ObservationalSponsor: University Health Network, TorontoUpdated: Aug 27, 2024Locations: 1Duration: 10 Years
Eligibility criteria

Atypical CML (aCML) [+11]

None

Read more